These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8962137)

  • 1. Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity.
    Naftzger C; Takechi Y; Kohda H; Hara I; Vijayasaradhi S; Houghton AN
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14809-14. PubMed ID: 8962137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein.
    Hara I; Takechi Y; Houghton AN
    J Exp Med; 1995 Nov; 182(5):1609-14. PubMed ID: 7595233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor immunity and autoimmunity induced by immunization with homologous DNA.
    Weber LW; Bowne WB; Wolchok JD; Srinivasan R; Qin J; Moroi Y; Clynes R; Song P; Lewis JJ; Houghton AN
    J Clin Invest; 1998 Sep; 102(6):1258-64. PubMed ID: 9739060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coupling and uncoupling of tumor immunity and autoimmunity.
    Bowne WB; Srinivasan R; Wolchok JD; Hawkins WG; Blachere NE; Dyall R; Lewis JJ; Houghton AN
    J Exp Med; 1999 Dec; 190(11):1717-22. PubMed ID: 10587362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.
    Overwijk WW; Lee DS; Surman DR; Irvine KR; Touloukian CE; Chan CC; Carroll MW; Moss B; Rosenberg SA; Restifo NP
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2982-7. PubMed ID: 10077623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A melanosomal membrane protein is a cell surface target for melanoma therapy.
    Takechi Y; Hara I; Naftzger C; Xu Y; Houghton AN
    Clin Cancer Res; 1996 Nov; 2(11):1837-42. PubMed ID: 9816138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated expression of melanoma antigen gp75 as immunotherapy for metastatic melanoma.
    Hirschowitz EA; Leonard S; Song W; Ferris B; Leopold PL; Lewis JJ; Bowne WB; Wang S; Houghton AN; Crystal RG
    Gene Ther; 1998 Jul; 5(7):975-83. PubMed ID: 9813669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc receptors are required in passive and active immunity to melanoma.
    Clynes R; Takechi Y; Moroi Y; Houghton A; Ravetch JV
    Proc Natl Acad Sci U S A; 1998 Jan; 95(2):652-6. PubMed ID: 9435247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of an autoantigenic 75-kDa human melanosomal glycoprotein.
    Vijayasaradhi S; Houghton AN
    Int J Cancer; 1991 Jan; 47(2):298-303. PubMed ID: 1671031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanocyte differentiation marker gp75, the brown locus protein, can be regulated independently of tyrosinase and pigmentation.
    Vijayasaradhi S; Doskoch PM; Wolchok J; Houghton AN
    J Invest Dermatol; 1995 Jul; 105(1):113-9. PubMed ID: 7615964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative roles for interferon-gamma in the immune response to DNA vaccines encoding related melanosomal antigens.
    Wolchok JD; Srinivasan R; Perales MA; Houghton AN; Bowne WB; Blachere NE
    Cancer Immun; 2001 Aug; 1():9. PubMed ID: 12747770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentivector immunization stimulates potent CD8 T cell responses against melanoma self-antigen tyrosinase-related protein 1 and generates antitumor immunity in mice.
    Liu Y; Peng Y; Mi M; Guevara-Patino J; Munn DH; Fu N; He Y
    J Immunol; 2009 May; 182(10):5960-9. PubMed ID: 19414747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Xenogeneic melanoma-related antigen elicits anti-tumor immune response, companied by autoimmune injury].
    Tan XH; Wan YH
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1596-600. PubMed ID: 16185524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor activity of human IgG1 anti-gp75 TA99 mAb against B16F10 melanoma in human FcgammaRI transgenic mice.
    Boross P; Jansen JH; van Tetering G; Nederend M; Brandsma A; Meyer S; Torfs E; van den Ham HJ; Meulenbroek L; de Haij S; Leusen JH
    Immunol Lett; 2014 Aug; 160(2):151-7. PubMed ID: 24613852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune rejection of mouse tumors expressing mutated self.
    Duan F; Lin Y; Liu C; Engelhorn ME; Cohen AD; Curran M; Sakaguchi S; Merghoub T; Terzulli S; Wolchok JD; Houghton AN
    Cancer Res; 2009 Apr; 69(8):3545-53. PubMed ID: 19351857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive transfer enables tumor rejection targeted against a self-antigen without the induction of autoimmunity.
    Eck SC; Turka LA
    Cancer Res; 2001 Apr; 61(7):3077-83. PubMed ID: 11306490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An exhaustion-like phenotype constrains the activity of CD4+ T cells specific for a self and melanoma antigen.
    Rausch MP; Hastings KT
    PLoS One; 2015; 10(4):e0123332. PubMed ID: 25875653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product.
    Vijayasaradhi S; Bouchard B; Houghton AN
    J Exp Med; 1990 Apr; 171(4):1375-80. PubMed ID: 2324688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aire deficiency promotes TRP-1-specific immune rejection of melanoma.
    Zhu ML; Nagavalli A; Su MA
    Cancer Res; 2013 Apr; 73(7):2104-16. PubMed ID: 23370329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular sorting and targeting of melanosomal membrane proteins: identification of signals for sorting of the human brown locus protein, gp75.
    Vijayasaradhi S; Xu Y; Bouchard B; Houghton AN
    J Cell Biol; 1995 Aug; 130(4):807-20. PubMed ID: 7642699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.